849
Views
43
CrossRef citations to date
0
Altmetric
Liver and biliary tract

Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy

, , , , , , , , , & show all
Pages 329-336 | Received 23 Jun 2015, Accepted 14 Sep 2015, Published online: 12 Oct 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Yooyun Chung, Mussarat N Rahim, Jonathon J Graham, Yoh Zen & Michael A Heneghan. (2021) An update on the pharmacological management of autoimmune hepatitis. Expert Opinion on Pharmacotherapy 22:11, pages 1475-1488.
Read now
Stuart K. Roberts, Simone I. Strasser, Amanda J. Nicoll, William Kemp, Ammar Majeed, Joanne Mitchell, Katherine Stuart, Paul Gow, Siddharth Sood, Gerry MacQuillan, Jacob George, Jonathan Mitchell & Geoffrey W. McCaughan. (2020) Efficacy and safety profile of calcineurin inhibitor salvage therapy in autoimmune hepatitis. Scandinavian Journal of Gastroenterology 55:11, pages 1309-1317.
Read now
Haider Al Taii, Mohamad A Hanouneh, Ibrahim Hanouneh, Rocio Lopez, Nizar Zein & Naim Alkhouri. (2017) The use of tacrolimus in refractory autoimmune hepatitis in children and adults: a single center experience. Scandinavian Journal of Gastroenterology 52:2, pages 157-158.
Read now

Articles from other publishers (40)

. (2023) KASL clinical practice guidelines for management of autoimmune hepatitis 2022. Clinical and Molecular Hepatology 29:3, pages 542-592.
Crossref
Ja Kyung Kim. (2023) Treatment of Autoimmune Hepatitis. The Korean Journal of Gastroenterology 81:2, pages 72-85.
Crossref
玉兰 朱. (2023) Diagnosis and Treatment of Autoimmune Hepatitis-Primary Biliary Cholangitis Overlap Syndrome. Advances in Clinical Medicine 13:03, pages 4678-4685.
Crossref
Ignasi Olivas, Sergio Rodríguez-Tajes & Maria Carlota Londoño. (2022) Hepatitis autoinmune: retos y novedades. Medicina Clínica 159:6, pages 289-298.
Crossref
Ignasi Olivas, Sergio Rodriguez-Tajes & Maria Carlota Londoño. (2022) Autoimmune hepatitis: Challenges and novelties. Medicina Clínica (English Edition) 159:6, pages 289-298.
Crossref
Diego Vergani, Benedetta Terziroli Beretta-Piccoli & Giorgina Mieli-Vergani. (2021) A reasoned approach to the treatment of autoimmune hepatitis. Digestive and Liver Disease 53:11, pages 1381-1393.
Crossref
Carlos Ferre-Aracil, Mar Riveiro-Barciela, María Trapero-Marugán, Manuel Rodríguez-Perálvarez, Laura-Patricia Llovet, Luis Téllez, Yolanda Sánchez-Torrijos, Fernando Díaz-Fontenla, Magdalena Salcedo-Plaza, Patricia Álvarez-López, Manuel de la Mata, María-Carlota Londoño, Rafael Bañares-Cañizares & José Luis Calleja. (2020) Tacrolimus as an Effective and Durable Second-Line Treatment for Chronic Autoimmune Hepatitis: A Multicentric Study. Digestive Diseases and Sciences 66:8, pages 2826-2832.
Crossref
Rodrigo Liberal, Ynto S de Boer & Michael A Heneghan. (2021) Established and novel therapeutic options for autoimmune hepatitis. The Lancet Gastroenterology & Hepatology 6:4, pages 315-326.
Crossref
Guiqiang Wang, Atsushi Tanaka, Hong Zhao, Jidong Jia, Xiong Ma, Kenichi Harada, Fu-Sheng Wang, Lai Wei, Qixia Wang, Ying Sun, Yuan Hong, Huiying Rao, Cumali Efe, George Lau, Diana Payawal, Rino Gani, Keith Lindor, Wasim Jafri, Masao Omata & Shiv Kumar Sarin. (2021) The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatology International 15:2, pages 223-257.
Crossref
Ansgar W. Lohse, Marcial Sebode, Marianne H. Jørgensen, Henriette Ytting, Tom H. Karlsen, Deirdre Kelly, Michael P. Manns & Mette Vesterhus. (2020) Second-line and third-line therapy for autoimmune hepatitis: A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group. Journal of Hepatology 73:6, pages 1496-1506.
Crossref
Mohammadreza Abdollahi, Neda Khalilian Ekrami, Morteza Ghojazadeh, H Marike Boezen, Mohammadhossein Somi & Behrooz Z Alizadeh. (2020) Tacrolimus and mycophenolate mofetil as second-line treatment in autoimmune hepatitis: Is the evidence of sufficient quality to develop recommendations?. World Journal of Gastroenterology 26:38, pages 5896-5910.
Crossref
Cara L. Mack, David Adams, David N. Assis, Nanda Kerkar, Michael P. Manns, Marlyn J. Mayo, John M. Vierling, Mouaz Alsawas, Mohammad H. Murad & Albert J. Czaja. (2020) Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology 72:2, pages 671-722.
Crossref
Albert J. Czaja. (2020) Review article: opportunities to improve and expand thiopurine therapy for autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 51:12, pages 1286-1304.
Crossref
Simon Pape, Frederik Nevens, Chris Verslype, Caroline Mertens, Joost P.H. Drenth & Eric T.T.L. Tjwa. (2020) Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience. European Journal of Gastroenterology & Hepatology 32:6, pages 727-732.
Crossref
Rodrigo Liberal, Giorgina Mieli-Vergani & Diego Vergani. 2020. Liver Immunology. Liver Immunology 419 441 .
Nwe Ni Than, James Hodson, Daniel Schmidt-Martin, Richard Taubert, Rebecca E. Wawman, Meemee Botter, Nishant Gautam, Kilian Bock, Rebecca Jones, Gautham D Appanna, Andrew Godkin, Aldo J. Montano-Loza, Frank Lammert, Christoph Schramm, Michael P. Manns, Mark Swain, Kelly W. Burak, David H. Adams, Gideon M Hirschfield & Ye Htun Oo. (2019) Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group. JHEP Reports 1:6, pages 437-445.
Crossref
Alana Persaud, Ahmed Ahmed, Gaurav Kakked, Oleg Shulik & Sushil Ahlawat. (2019) Association of Autoimmune Hepatitis and Cardiovascular Disease. Digestive and Liver Disease 51:11, pages 1604-1609.
Crossref
Marilena Durazzo, Giulia Lupi, Michela Scandella, Arianna Ferro & Gabriella Gruden. (2019) Autoimmune hepatitis treatment in the elderly: A systematic review. World Journal of Gastroenterology 25:22, pages 2809-2818.
Crossref
Iliana Doycheva, Kymberly D. Watt & Aliya F. Gulamhusein. (2019) Autoimmune hepatitis: Current and future therapeutic options. Liver International 39:6, pages 1002-1013.
Crossref
Palak J. Trivedi, Stefan G. Hubscher, Michael Heneghan, Dermot Gleeson & Gideon M. Hirschfield. (2019) Grand round: Autoimmune hepatitis. Journal of Hepatology 70:4, pages 773-784.
Crossref
Jessica K. Dyson, Eleonora De Martin, George N. Dalekos, Joost P.H. Drenth, Johannes Herkel, Stefan G. Hubscher, Deirdre Kelly, Marco Lenzi, Piotr Milkiewicz, Ye H. Oo, Michael A. Heneghan & Ansgar W. Lohse. (2019) Review article: unanswered clinical and research questions in autoimmune hepatitis-conclusions of the International Autoimmune Hepatitis Group Research Workshop. Alimentary Pharmacology & Therapeutics 49:5, pages 528-536.
Crossref
Ashnila Janmohamed & Gideon M Hirschfield. (2019) Autoimmune hepatitis and complexities in management. Frontline Gastroenterology 10:1, pages 77-87.
Crossref
Carolin F. Manthey, Marcial Sebode, Helen Hayward-Koennecke, Andreas Lutterotti & Samuel Huber. 2019. Nijkamp and Parnham's Principles of Immunopharmacology. Nijkamp and Parnham's Principles of Immunopharmacology 751 775 .
Jessica K. Dyson, Lin Lee Wong, Theophile Bigirumurame, Gideon M. Hirschfield, Stuart Kendrick, Ye H. Oo, Ansgar W Lohse, Michael A. Heneghan & David E. J. Jones. (2018) Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom. Alimentary Pharmacology & Therapeutics 48:9, pages 951-960.
Crossref
Lars Bossen, Alessio Gerussi, Vasiliki Lygoura, George F. Mells, Marco Carbone & Pietro Invernizzi. (2018) Support of precision medicine through risk-stratification in autoimmune liver diseases – histology, scoring systems, and non-invasive markers. Autoimmunity Reviews 17:9, pages 854-865.
Crossref
Keaton R. Jones & Craig S. Lammert. (2018) Management of Autoimmune Hepatitis Patients Refractory to or Intolerant of Standard Therapies. Current Hepatology Reports 17:3, pages 166-174.
Crossref
Y. S. de Boer, R. Liberal & M. A. Heneghan. (2018) Letter: tacrolimus may be hazardous in decompensated autoimmune liver disease with hyperbilirubinemia-authors’ reply. Alimentary Pharmacology & Therapeutics 47:11, pages 1568-1569.
Crossref
David Jones, Michael P Manns, Luigi Terracciano, Michael Torbenson & John M Vierling. (2018) Unmet needs and new models for future trials in autoimmune hepatitis. The Lancet Gastroenterology & Hepatology 3:5, pages 363-370.
Crossref
Cumali Efe, Haider Al Taii, Henriette Ytting, Niklas Aehling, Rahima A. Bhanji, Hannes Hagström, Tugrul Purnak, Luigi Muratori, Mårten Werner, Paolo Muratori, Daniel Klintman, Thomas D. Schiano, Aldo J. Montano-Loza, Thomas Berg, Fin Stolze Larsen, Naim Alkhouri, Ersan Ozaslan, Michael A. Heneghan, Eric M. Yoshida & Staffan Wahlin. (2018) Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis. Digestive Diseases and Sciences 63:5, pages 1348-1354.
Crossref
Feng‑Bin Lu, En‑De Hu Hu, Lan‑Man Xu, Yi‑Bing Hu, Lu Chen, Jin‑Lu Wu, Hui Li, Da‑Zhi Chen & Yong‑Ping Chen. (2018) Comparative efficacy and tolerability of treatments for adult autoimmune hepatitis: A systematic review and network meta‑analysis. Experimental and Therapeutic Medicine.
Crossref
Giorgina Mieli-Vergani, Diego Vergani, Albert J. Czaja, Michael P. Manns, Edward L. Krawitt, John M. Vierling, Ansgar W. Lohse & Aldo J. Montano-Loza. (2018) Autoimmune hepatitis. Nature Reviews Disease Primers 4:1.
Crossref
Qi-Xia Wang, Li Yan & Xiong Ma. (2017) Autoimmune Hepatitis in the Asia-Pacific Area. Journal of Clinical and Translational Hepatology 6:1, pages 1-9.
Crossref
Timur Liwinski & Christoph Schramm. (2017) Autoimmune hepatitis — update on clinical management in 2017. Clinics and Research in Hepatology and Gastroenterology 41:6, pages 617-625.
Crossref
Cumali Efe, Hannes Hagström, Henriette Ytting, Rahima A. Bhanji, Niklas F. Müller, Qixia Wang, Tugrul Purnak, Luigi Muratori, Mårten Werner, Hanns-Ulrich Marschall, Paolo Muratori, Fulya Gunşar, Daniel Klintman, Albert Parés, Alexandra Heurgué–Berlot, Thomas D. Schiano, Mustafa Cengiz, Michele May-Sien Tana, Xiong Ma, Aldo J. Montano-Loza, Thomas Berg, Sumita Verma, Fin Stolze Larsen, Ersan Ozaslan, Michael A. Heneghan, Eric M. Yoshida & Staffan Wahlin. (2017) Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology 15:12, pages 1950-1956.e1.
Crossref
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani & Diego Vergani. (2017) Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments. World Journal of Gastroenterology 23:33, pages 6030-6048.
Crossref
Angela Cropley & Martin Weltman. (2017) The use of immunosuppression in autoimmune hepatitis: A current literature review. Clinical and Molecular Hepatology 23:1, pages 22-26.
Crossref
R. Liberal, Y. S. de Boer, R. J. Andrade, G. Bouma, G. N. Dalekos, A. Floreani, D. Gleeson, G. M. Hirschfield, P. Invernizzi, M. Lenzi, A. W. Lohse, G. Macedo, P. Milkiewicz, B. Terziroli, B. van Hoek, J. M. Vierling & M. A. Heneghan. (2017) Expert clinical management of autoimmune hepatitis in the real world. Alimentary Pharmacology & Therapeutics 45:5, pages 723-732.
Crossref
Rodrigo Liberal, Edward L. Krawitt, John M. Vierling, Michael P. Manns, Giorgina Mieli-Vergani & Diego Vergani. (2016) Cutting edge issues in autoimmune hepatitis. Journal of Autoimmunity 75, pages 6-19.
Crossref
Nwe Ni Than, Hannah C. Jeffery & Ye H. Oo. (2016) Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy. Canadian Journal of Gastroenterology and Hepatology 2016, pages 1-12.
Crossref
. (2016) Tacrolimus. Reactions Weekly 1584:1, pages 184-184.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.